| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
77,921,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
4,773,204 |
Avg
Vol: |
2,175,956 |
| 52
Week Range: |
$81.49 - $81.49 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
| |
NASDAQ COMPOSITE |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Roche Robert P Jr |
Exec VP, WW Pharmaceutical Ops |
• – – |
2007-11-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
20 |
44,210 |
|
- |
|
| Roche Robert P Jr |
Exec VP, WW Pharmaceutical Ops |
• – – |
2007-11-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
10 |
44,230 |
|
- |
|
| Baldino Frank Jr |
Chairman & CEO |
• • – |
2007-11-19 |
4 |
S |
$74.28 |
$3,793,720 |
D/D |
(50,809) |
382,975 |
|
- |
|
| Baldino Frank Jr |
Chairman & CEO |
• • – |
2007-11-19 |
4 |
OE |
$10.50 |
$630,000 |
D/D |
60,000 |
433,784 |
|
- |
|
| Baldino Frank Jr |
Chairman & CEO |
• • – |
2007-11-19 |
4 |
S |
$75.02 |
$130,818 |
D/D |
(1,743) |
380,927 |
|
- |
|
| Baldino Frank Jr |
Chairman & CEO |
• • – |
2007-11-19 |
4 |
D |
$75.04 |
$22,887 |
D/D |
(305) |
382,375 |
|
- |
|
| Greenacre Martyn D |
Director |
– • – |
2007-05-30 |
4 |
S |
$81.38 |
$407,135 |
D/D |
(5,000) |
0 |
|
- |
|
| Greenacre Martyn D |
Director |
– • – |
2007-05-30 |
4 |
OE |
$12.38 |
$61,875 |
D/D |
5,000 |
5,000 |
|
- |
|
| Osborn John E |
Exec VP, General Counsel & Sec |
• – – |
2007-05-25 |
4 |
S |
$80.00 |
$2,113,275 |
D/D |
(26,375) |
39,000 |
|
- |
|
| Osborn John E |
Exec VP, General Counsel & Sec |
• – – |
2007-05-25 |
4 |
OE |
$51.08 |
$1,348,484 |
D/D |
26,375 |
65,375 |
|
- |
|
| Russell Lesley |
Exec. VP, WW Med & Reg Affairs |
• – – |
2007-05-09 |
4 |
S |
$80.00 |
$124,732 |
D/D |
(1,559) |
17,277 |
|
- |
|
| Osborn John E |
Exec VP, General Counsel & Sec |
• – – |
2007-05-07 |
4 |
S |
$81.00 |
$911,250 |
D/D |
(11,250) |
39,000 |
|
- |
|
| Osborn John E |
Exec VP, General Counsel & Sec |
• – – |
2007-05-07 |
4 |
OE |
$48.06 |
$541,550 |
D/D |
11,250 |
50,250 |
|
- |
|
| Roche Robert P Jr |
Exec VP, WW Pharmaceutical Ops |
• – – |
2007-02-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
200 |
44,240 |
|
- |
|
| Buchi J Kevin |
Exec. Vice President & CFO |
• – – |
2007-02-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
280 |
94,454 |
|
- |
|
| Grebow Peter E |
Exec VP,Worldwide Tech Ops. |
• – – |
2007-02-20 |
4 |
S |
$74.25 |
$445,550 |
D/D |
(6,000) |
54,515 |
|
- |
|
| Grebow Peter E |
Exec VP,Worldwide Tech Ops. |
• – – |
2007-02-16 |
4 |
D |
$75.70 |
$99,924 |
D/D |
(1,320) |
60,515 |
|
- |
|
| Grebow Peter E |
Exec VP,Worldwide Tech Ops. |
• – – |
2007-02-16 |
4 |
OE |
$48.20 |
$99,967 |
D/D |
2,074 |
61,835 |
|
- |
|
| Grebow Peter E |
Exec VP,Worldwide Tech Ops. |
• – – |
2007-02-16 |
4 |
S |
$75.13 |
$778,242 |
D/D |
(10,345) |
59,761 |
|
- |
|
| Grebow Peter E |
Exec VP,Worldwide Tech Ops. |
• – – |
2007-02-16 |
4 |
S |
$75.34 |
$2,992,591 |
D/D |
(39,655) |
70,106 |
|
- |
|
| Grebow Peter E |
Exec VP,Worldwide Tech Ops. |
• – – |
2007-02-16 |
4 |
OE |
$51.17 |
$2,558,500 |
D/D |
50,000 |
109,761 |
|
- |
|
| Egan William P |
Director |
– • – |
2007-02-16 |
4 |
S |
$75.06 |
$751,233 |
D/D |
(10,000) |
0 |
|
- |
|
| Egan William P |
Director |
– • – |
2007-02-16 |
4 |
OE |
$12.88 |
$128,750 |
D/D |
10,000 |
10,000 |
|
- |
|
| Baldino Frank Jr |
Chairman & CEO |
• • – |
2007-02-01 |
4 |
D |
$73.15 |
$27,578 |
D/D |
(377) |
373,784 |
|
- |
|
| Roche Robert P Jr |
Exec VP, Worldwide Pharm Ops. |
• – – |
2006-12-22 |
4 |
S |
$69.75 |
$236,104 |
D/D |
(3,385) |
44,440 |
|
- |
|
491 Records found
|
|
Page 11 of 20 |
|
|
